세포 치료 기술 시장 규모, 점유율, 동향, 산업 분석 보고서 : 치료 유형별, 기술별, 용도별, 지역별 - 시장 예측(2025-2034년)

The global cell therapy technologies market size is expected to reach USD 44.43 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Therapy Technologies Market Size, Share, Trends, Industry Analysis Report: By Therapy Type (Allogeneic Therapies and Autologous Therapies), Technology, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cell therapy technologies encompass the tools, equipment, and systems used to develop, manufacture, and deliver cell-based therapies for treating various diseases. These technologies support key processes such as cell isolation, expansion, modification, and preservation to ensure the viability and functionality of therapeutic cells. They are widely utilized in regenerative medicine, immunotherapy, and stem cell research, aiding in the treatment of conditions such as cancer, neurological disorders, cardiovascular diseases, and autoimmune disorders. With advancements in gene editing, bioprocessing, and cryopreservation, cell therapy technologies continue to play a pivotal role in enhancing the safety, scalability, and efficacy of cell-based treatments.

The cell therapy technologies market expansion is driven by increasing research in regenerative medicine and the rising demand for innovative treatment options. The market benefits from advancements in automation, bioreactor technology, and genome editing tools that streamline manufacturing processes and improve therapeutic outcomes. Regulatory support for cell-based therapies, along with growing investments from biotechnology firms and healthcare institutions, is further fueling market growth. Additionally, collaborations between research organizations and industry players are accelerating technological developments, ensuring wider accessibility of cell therapy solutions. As personalized medicine gains momentum, the demand for efficient and scalable cell therapy technologies is expected to rise, shaping the future of modern healthcare.

Cell Therapy Technologies Market Report Highlights

By therapy type, the autologous therapies segment holds a larger cell therapy technologies market share due to their lower risk of immune rejection and increasing adoption in personalized medicine. These therapies are widely used in regenerative medicine and oncology treatments, contributing to their dominance in the market.

By technology, the viral vector technology segment leads the market, as it plays a crucial role in gene and cell therapy applications by enabling precise genetic modifications. Its established use in developing advanced therapies, such as CAR-T cell therapy, ensures its widespread adoption and high market demand.

By application, oncology was the dominant segment in 2024 due to the rising prevalence of cancer and the growing adoption of cell-based immunotherapies. The increasing number of regulatory approvals for cell therapy products in oncology has strengthened its position in the market.

By region, North America holds the largest share of the cell therapy technologies market revenue. This is attributed to the region's advanced healthcare infrastructure, substantial investments in research and development, and a supportive regulatory environment.

The cell therapy technologies market features several prominent companies actively contributing to its advancement. A few key players include Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Lonza Group AG; Sartorius AG; Agilent Technologies Inc.; Avantor, Inc.; Bio-Techne Corporation; Fresenius SE & Co. KGaA; Becton, Dickinson and Company (BD); Corning Incorporated; and Terumo Corporation.

Polaris Market Research has segmented the Cell Therapy Technologies market report on the basis of therapy type, technology, application, and region:

By Therapy Type Outlook (Revenue - USD Billion, 2020-2034)

Allogeneic Therapies

Autologous Therapies

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Somatic Cell Technology

Cell Immortalization Technology

Viral Vector Technology

Genome Editing Technology

Cell Plasticity Technology

By Application Outlook (Revenue - USD Billion, 2020-2034)

Musculoskeletal

Cardiovascular

Gastrointestinal

Neurological

Oncology

Dermatology

Wound and Injuries

Ocular

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Source
  • 3.2.1. Primary Source
  • 3.2.2. Secondary Source

4. Global Cell Therapy Technologies Market Insights

• 4.1. Cell Therapy Technologies Market - Market Snapshot
• 4.2. Cell Therapy Technologies Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Government Funding and Support
    • 4.2.1.2. Advancements in Gene Editing Technologies
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Complex regulatory approval process
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Cell Therapy Technologies Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Cell Therapy Technologies Market, by Therapy Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
• 5.3. Allogeneic Therapies
  • 5.3.1. Global Cell Therapy Technologies Market, by Allogeneic Therapies, by Region, 2020-2034 (USD Billion)
• 5.4. Autologous Therapies
  • 5.4.1. Global Cell Therapy Technologies Market, by Autologous Therapies, by Region, 2020-2034 (USD Billion)

6. Global Cell Therapy Technologies Market, by Technology

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
• 6.3. Somatic Cell Technology
  • 6.3.1. Global Cell Therapy Technologies Market, by Somatic Cell Technology, by Region, 2020-2034 (USD Billion)
• 6.4. Cell Immortalization Technology
  • 6.4.1. Global Cell Therapy Technologies Market, by Cell Immortalization Technology, by Region, 2020-2034 (USD Billion)
• 6.5. Viral Vector Technology
  • 6.5.1. Global Cell Therapy Technologies Market, by Viral Vector Technology, by Region, 2020-2034 (USD Billion)
• 6.6. Genome Editing Technology
  • 6.6.1. Global Cell Therapy Technologies Market, by Genome Editing Technology, by Region, 2020-2034 (USD Billion)
• 6.7. Cell Plasticity Technology
  • 6.7.1. Global Cell Therapy Technologies Market, by Cell Plasticity Technology, by Region, 2020-2034 (USD Billion)

7. Global Cell Therapy Technologies Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
• 7.3. Musculoskeletal
  • 7.3.1. Global Cell Therapy Technologies Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
• 7.4. Cardiovascular
  • 7.4.1. Global Cell Therapy Technologies Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
• 7.5. Gastrointestinal
  • 7.5.1. Global Cell Therapy Technologies Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)
• 7.6. Neurological
  • 7.6.1. Global Cell Therapy Technologies Market, by Neurological, by Region, 2020-2034 (USD Billion)
• 7.7. Oncology
  • 7.7.1. Global Cell Therapy Technologies Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 7.8. Dermatology
  • 7.8.1. Global Cell Therapy Technologies Market, by Dermatology, by Region, 2020-2034 (USD Billion)
• 7.9. Wound and Injuries
  • 7.9.1. Global Cell Therapy Technologies Market, by Wound and Injuries, by Region, 2020-2034 (USD Billion)
• 7.10. Ocular
  • 7.10.1. Global Cell Therapy Technologies Market, by Ocular, by Region, 2020-2034 (USD Billion)
• 7.11. Others
  • 7.11.1. Global Cell Therapy Technologies Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Cell Therapy Technologies Market, by Geography

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Cell Therapy Technologies Market Assessment, By Geography, 2020-2034 (USD Billion)
• 8.3. Cell Therapy Technologies Market - North America
  • 8.3.1. North America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • 8.3.2. North America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • 8.3.3. North America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.3.4. Cell Therapy Technologies Market - U.S.
    • 8.3.4.1. U.S.: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.3.4.2. U.S.: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.4.3. U.S.: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.3.5. Cell Therapy Technologies Market - Canada
    • 8.3.5.1. Canada: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.3.5.2. Canada: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.5.3. Canada: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
• 8.4. Cell Therapy Technologies Market - Europe
  • 8.4.1. Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • 8.4.2. Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • 8.4.3. Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.4. Cell Therapy Technologies Market - UK
    • 8.4.4.1. UK: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.4.2. UK: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.4.3. UK: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.5. Cell Therapy Technologies Market - France
    • 8.4.5.1. France: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.5.2. France: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.5.3. France: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.6. Cell Therapy Technologies Market - Germany
    • 8.4.6.1. Germany: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.6.2. Germany: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.6.3. Germany: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.7. Cell Therapy Technologies Market - Italy
    • 8.4.7.1. Italy: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.7.2. Italy: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.7.3. Italy: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.8. Cell Therapy Technologies Market - Spain
    • 8.4.8.1. Spain: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.8.2. Spain: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.8.3. Spain: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.9. Cell Therapy Technologies Market - Netherlands
    • 8.4.9.1. Netherlands: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.9.2. Netherlands: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.9.3. Netherlands: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.10. Cell Therapy Technologies Market - Russia
    • 8.4.10.1. Russia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.10.2. Russia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.10.3. Russia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.4.11. Cell Therapy Technologies Market - Rest of Europe
    • 8.4.11.1. Rest of Europe: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.4.11.2. Rest of Europe: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.11.3. Rest of Europe: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
• 8.5. Cell Therapy Technologies Market - Asia Pacific
  • 8.5.1. Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • 8.5.2. Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • 8.5.3. Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.4. Cell Therapy Technologies Market - China
    • 8.5.4.1. China: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.4.2. China: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.4.3. China: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.5. Cell Therapy Technologies Market - India
    • 8.5.5.1. India: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.5.2. India: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.5.3. India: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.6. Cell Therapy Technologies Market - Malaysia
    • 8.5.6.1. Malaysia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.6.2. Malaysia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.6.3. Malaysia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.7. Cell Therapy Technologies Market - Japan
    • 8.5.7.1. Japan: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.7.2. Japan: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.7.3. Japan: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.8. Cell Therapy Technologies Market - Indonesia
    • 8.5.8.1. Indonesia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.8.2. Indonesia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.8.3. Indonesia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.9. Cell Therapy Technologies Market - South Korea
    • 8.5.9.1. South Korea: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.9.2. South Korea: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.9.3. South Korea: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.10. Cell Therapy Technologies Market - Australia
    • 8.5.10.1. Australia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.10.2. Australia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.10.3. Australia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.5.11. Cell Therapy Technologies Market - Rest of Asia Pacific
    • 8.5.11.1. Rest of Asia Pacific: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.5.11.2. Rest of Asia Pacific: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.11.3. Rest of Asia Pacific: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
• 8.6. Cell Therapy Technologies Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • 8.6.2. Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • 8.6.3. Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.6.4. Cell Therapy Technologies Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.6.4.2. Saudi Arabia: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.4.3. Saudi Arabia: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.6.5. Cell Therapy Technologies Market - UAE
    • 8.6.5.1. UAE: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.6.5.2. UAE: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.5.3. UAE: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.6.6. Cell Therapy Technologies Market - Israel
    • 8.6.6.1. Israel: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.6.6.2. Israel: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.6.3. Israel: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.6.7. Cell Therapy Technologies Market - South Africa
    • 8.6.7.1. South Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.6.7.2. South Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.7.3. South Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.6.8. Cell Therapy Technologies Market - Rest of Middle East & Africa
    • 8.6.8.1. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.6.8.2. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.8.3. Rest of Middle East & Africa: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
• 8.7. Cell Therapy Technologies Market - Latin America
  • 8.7.1. Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
  • 8.7.2. Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
  • 8.7.3. Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.7.4. Cell Therapy Technologies Market - Mexico
    • 8.7.4.1. Mexico: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.7.4.2. Mexico: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.4.3. Mexico: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.7.5. Cell Therapy Technologies Market - Brazil
    • 8.7.5.1. Brazil: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.7.5.2. Brazil: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.5.3. Brazil: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.7.6. Cell Therapy Technologies Market - Argentina
    • 8.7.6.1. Argentina: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.7.6.2. Argentina: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.6.3. Argentina: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)
  • 8.7.7. Cell Therapy Technologies Market - Rest of Latin America
    • 8.7.7.1. Rest of Latin America: Cell Therapy Technologies Market, by Therapy Type, 2020-2034 (USD Billion)
    • 8.7.7.2. Rest of Latin America: Cell Therapy Technologies Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.7.3. Rest of Latin America: Cell Therapy Technologies Market, by Application, 2020-2034 (USD Billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Agilent Technologies Inc.
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. Avantor, Inc.
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. Becton, Dickinson and Company (BD)
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Bio-Techne Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. Corning Incorporated
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. Danaher Corporation
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. Fresenius SE & Co. KGaA
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. Lonza Group AG
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Merck KGaA
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. Sartorius AG
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. Terumo Corporation
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. Thermo Fisher Scientific Inc
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development